Skip to main content
OpenTrials

Clinical trial condition

Endometrial Cancer

Explore clinical trials studying Endometrial Cancer. Study availability and eligibility vary by location and protocol.

618 public trials 193 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Cancer trial results

Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT06132958

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • USA Mitchell Cancer Institute ( Site 4142) Mobile, Alabama, United States
  • Alaska Womens Cancer Care ( Site 4122) Anchorage, Alaska, United States
  • HonorHealth (HH) ( Site 8000) Phoenix, Arizona, United States
  • Arizona Oncology Associates - HOPE ( Site 8002) Tucson, Arizona, United States
View all 241 locations
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Abemaciclib and Letrozole to Treat Endometrial Cancer

NCT04393285

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of South Alabama Mitchell Cancer Center Mobile, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Smillow Cancer Care at Greenwich Greenwich, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT05527184

Conditions
Adnexal Diseases, Cervical Cancer, Disease Attributes, +23 more
Locations
  • University of Alabama at Birmingham /ID# 269045 Birmingham, Alabama, United States
  • City of Hope National Medical Center /ID# 269036 Duarte, California, United States
  • Moores Cancer Center /ID# 269040 La Jolla, California, United States
  • University of California Los Angeles Medical Center /ID# 269037 Los Angeles, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details

Related conditions